Hers
Hers is the women's telehealth division of Hims & Hers Health, Inc. (NYSE: HIMS), offering direct-to-consumer virtual consultations, prescription medications, and lab testing across weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, and preventive screening to women in all 50 U.S. states on a cash-pay basis.
- Company typePublic
- Founded2017
- HeadquartersSan Francisco, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Hers does
Hers is a women's telehealth brand and division of Hims & Hers Health, Inc. (NYSE: HIMS), founded in 2017 and headquartered at 2269 Chestnut Street #523, San Francisco. It operates a direct-to-consumer virtual care platform that connects patients in all 50 U.S. states with licensed providers through an asynchronous digital intake flow plus 24/7 in-app messaging, dispensing prescription and OTC products via a network of partner pharmacies (Apostrophe, XeCare, Curexa, Red Rock, AnazaoHealth, Strive) and routing blood draws through 2,000+ Quest Diagnostics locations. Services are cash-pay only, with no insurance accepted for most offerings, and FSA/HSA cards are supported.
The product portfolio spans five primary verticals: (1) GLP-1 weight loss medication access — a membership-gated stack ($39 first month then $149/month) covering Wegovy Pill, Wegovy Pen, Zepbound KwikPen, Zepbound Vial, Foundayo, and Ozempic, leveraging Novo Nordisk's SNAC absorption technology and Eli Lilly's dual GLP-1/GIP and small-molecule oral mechanisms; (2) hair regrowth — topical, oral, and foam minoxidil formulations plus combination supplements; (3) menopause/perimenopause hormone replacement therapy — estradiol pills/patches/vaginal cream and progesterone; (4) preventive health — Labs by Hers subscription at $199/year (Base) or $499/year (Advanced), with 130+ biomarkers, biological age calculation, and an integrated GRAIL Galleri multi-cancer test; and (5) general women's health — birth control, mental health (bupropion, escitalopram, propranolol), sexual wellness, valacyclovir, and prescription skincare. The platform is led by CMO Dr. Jessica Shepherd and supported by an endocrinologist and cardiologist advisor bench; financial scale reached 500,000+ users by late 2025 with an explicit target of surpassing $1 billion in revenue by 2026.
Hers firmographics
Firmographics- Name
- Hers
- Legal name
- Hims & Hers Health, Inc.
- Website
- https://forhers.com
- Company type
- Public
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Hers is the women's telehealth division of Hims & Hers Health, Inc. (NYSE: HIMS), offering direct-to-consumer virtual consultations, prescription medications, and lab testing across weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, and preventive screening to women in all 50 U.S. states on a cash-pay basis.
- Ownership category
- akta.pro rank
Hers industry classification
Industry- Product category
- Women's Telehealth / Digital Health
- NAICS
- Other Ambulatory Health Care Services (6219)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)
- akta.pro secondary industries
- Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD), Contraception & Family Planning Telehealth (birth control, counseling, follow-up) (HLALAHAB)
Keywords
Where Hers is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Hers business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Operations, Infrastructure
Revenue model
- Weight Loss Membership: Monthly subscription membership providing access to GLP-1 medications including Wegovy, Zepbound, Foundayo, and Ozempic. Membership includes 24/7 provider messaging, unlimited dosage adjustments, and clinical care. Medication costs billed separately.
- GLP-1 Medication Sales: Revenue from prescription GLP-1 medications including Wegovy Pill ($149+/month), Wegovy Pen ($199+/month), Zepbound KwikPen ($299/month), Zepbound Vial ($299/month), Ozempic Pill ($149+/month), and Foundayo Pill ($149+/month). Prices vary by medication type and dosage.
- Lab Testing Subscriptions: Annual subscription-based lab testing service with two tiers: Base Plan at $199/year covering ~50 biomarkers and Advanced Plan at $499/year covering 120+ biomarkers. Includes cancer screening option via Galleri test.
- Hair Loss Treatment: Revenue from minoxidil-based products (topical solutions, oral minoxidil, hair vitamins, gummies). Products priced around $45 for topical solution. Subscription discounts available.
- Menopause/Hormone Treatment: Prescription hormone replacement therapies including estradiol pills/patches, progesterone pills, and vaginal creams. Costs range from $12/month for birth control to treatments for menopause symptoms.
- Mental Health/Sexual Wellness: Various prescription and OTC products for mental health (bupropion, escitalopram, propranolol) and sexual wellness, sold via subscription model.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Weight Loss Membership |
| Subscription | Monthly | Wegovy Pill |
| Subscription | Monthly | Wegovy Pen |
| Subscription | Monthly | Zepbound KwikPen |
| Subscription | Monthly | Zepbound Vial |
| Subscription | Monthly | Ozempic Pill |
| Subscription | Monthly | Foundayo Pill |
| Subscription | Annual | Labs by Hers - Base Plan |
| Subscription | Annual | Labs by Hers - Advanced Plan |
| Subscription | Monthly | Hair Minoxidil Solution |
| Subscription | Monthly | Birth Control |
| Subscription | Monthly | Menopause Treatment |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
Hers product offering
Product offeringCore offering
Hers is a women-focused direct-to-consumer telehealth platform that connects patients with licensed healthcare providers via online questionnaires, asynchronous review, and 24/7 messaging. It dispenses FDA-approved prescription medications for weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, birth control, and sexual wellness, and offers subscription-based lab testing (Labs by Hers) processed through Quest Diagnostics. All services are cash-pay with no insurance required, and prescriptions are shipped in discreet packaging through partner pharmacies.
Product overview
Hers is a women-focused multispecialty telehealth platform offering virtual consultations with licensed healthcare providers across all 50 U.S. states on a cash-pay-only basis. The platform provides prescription medications, over-the-counter treatments, and lab testing services for conditions including hair loss, weight management, menopause, mental health, birth control, sexual wellness, and skincare. The core portfolio includes GLP-1 weight loss medications (Wegovy Pill, Wegovy Pen, Zepbound KwikPen, Zepbound Vial, Foundayo Pill, Ozempic Pill) accessible via the Hers Weight Loss Membership; hair regrowth treatments (Minoxidil Topical Solution, Oral Minoxidil, Foam Minoxidil, Hair Vitamins + Minoxidil); menopause hormone replacement therapies (Estradiol Pill/Patch, Estradiol Vaginal Cream, Progesterone Pill); and Labs by Hers for biomarker testing and cancer screening. All services are accessed through the Hers app with discreet medication shipping.
Differentiator
Problem solved
Functional benefit
Brands
- Labs by Hers: Subscription-based direct-to-consumer lab testing service offering 130+ biomarker tests, cancer screening, and personalized health action plans.
Products and services
- Wegovy Pill FDA-approved once-daily oral GLP-1 medication containing semaglutide for weight loss; clinically proven to help people lose 32 lbs in one year on average using SNAC molecule absorption technology; requires Hers Weight Loss Membership.
- Wegovy Pen FDA-approved once-weekly GLP-1 injection containing semaglutide; clinically proven to help people lose 35 lbs in one year on average; available in dosages from 0.25 mg to 7.2 mg; priced from $199/month.
- Zepbound KwikPen FDA-approved once-weekly GLP-1 injection containing tirzepatide; targets both GLP-1 and GIP receptors; pre-filled pen with 4 doses; lose up to 21% body weight; priced at $299/month.
- Zepbound Vial FDA-approved weekly GLP-1 injection containing tirzepatide in vial form for weight loss; priced at $299/month.
- Foundayo Pill FDA-approved once-daily oral GLP-1 pill containing orforglipron (small-molecule formulation); clinically proven to help lose 11% body weight on average in over a year; no food, water, or timing restrictions; priced from $149/month.
- Ozempic Pill Daily GLP-1 medication containing semaglutide for improving blood sugar levels in adults with Type 2 diabetes; may be prescribed off-label through Hers; priced from $149/month.
- Minoxidil Topical Solution 2% FDA-approved topical 2% minoxidil hair regrowth treatment applied daily; regrows hair in 3-6 months; priced at approximately $45/month.
- Oral Minoxidil Prescription oral minoxidil for hair regrowth; daily pill alternative to topical minoxidil application.
- Hair Vitamins + Minoxidil Combined supplement and topical minoxidil treatment pairing oral hair vitamins with daily minoxidil application.
- Estradiol Pill or Patch FDA-approved hormone replacement therapy in pill or transdermal patch form for postmenopausal women; prescribed off-label for perimenopausal symptoms including hot flashes.
- Estradiol Vaginal Cream Topical vaginal estradiol cream for menopause-related vaginal dryness, itching, and irritation; clinically proven to improve vaginal lining thickness.
- Progesterone Pill Progesterone supplement for menopausal women with a uterus taking estrogen HRT; helps protect the uterine lining.
- Labs by Hers Advanced Plan Annual subscription-based lab testing service covering 130+ biomarkers across 10 health areas (heart, metabolic, hormone, thyroid, kidney, liver, immune, nutrients, blood); tests twice per year at Quest Diagnostics locations; priced at $499/year after launch pricing.
- Labs by Hers Base Plan Entry-level annual lab testing subscription covering approximately 50 biomarkers; first draw tests 75+ biomarkers; 6-month retest covers 55+ biomarkers; priced at $199/year.
- Multi-Cancer Test by Galleri Multi-cancer detection screening test by GRAIL via single blood draw; screens for over 50 cancer types; recommended for adults 50+ or those with elevated cancer risk; processed at CLIA-certified laboratory.
- Birth Control Telehealth consultations and prescriptions for birth control medications; cash-pay model with no insurance required; costs from $12/month.
- Hers Weight Loss Membership Monthly subscription membership required to access Hers weight loss medications; includes provider evaluation, 24/7 messaging, unlimited dosage adjustments, peer support community, and exclusive lifestyle brand discounts; first month $39, then $149/month auto-renewing; medication cost billed separately.
Quantifiable outcome
- Lose up to 25% body weight with Wegovy Pen
- +6 more outcomes
Companies that use Hers
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Hers technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Hers partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered minor and core.
- CVS HealthminorCVS Health featured Hers products in Spring Epic Beauty Event promotion (March 1-28, 2026) with markdowns on Hers Minoxidil and other beauty products available both in-store and online.
- GRAIL, Inc.coreGRAIL provides the Galleri multi-cancer detection test through Hers Labs. The test screens for 50+ cancer types with a single blood draw. GRAIL clinical laboratory is CLIA-certified and CAP-accredited. GRAIL develops and determines performance characteristics; Hers offers as part of coordinated offering.
- Quest Diagnostics IncorporatedcoreQuest Diagnostics processes all Hers lab testing panels. Customers book appointments at 2,000+ Quest locations nationwide through the Hers app. Quest provides the blood draw infrastructure for Hers Labs by Hers biomarker testing.
- Novo Nordisk A/ScoreNovo Nordisk manufactures Wegovy (semaglutide) and Ozempic (semaglutide). Hers offers these FDA-approved GLP-1 medications through its telehealth platform. Novo Nordisk developed SNAC molecule technology for oral semaglutide absorption.
- Eli Lilly and CompanycoreEli Lilly manufactures Zepbound (tirzepatide) and Foundayo (orforglipron). Hers offers these FDA-approved GLP-1 medications through its platform. Zepbound targets both GLP-1 and GIP receptors. Foundayo is a trademark of Eli Lilly.
- Apostrophe Pharmacy LLCcorePrimary pharmacy fulfillment partner for Hers prescriptions. One of several pharmacies that fill prescriptions ordered through the Hers platform. Prescriptions may be transferred between partner pharmacies.
- XeCare LLCcorePharmacy fulfillment partner for Hers prescription medications. Part of the pharmacy network that fills and ships prescriptions to customers.
- Curexa (EHT Pharmacy LLC)corePharmacy fulfillment partner (dba Curexa) for Hers prescriptions. Part of the pharmacy network handling prescription fulfillment and shipping.
- Red Rock Pharmacy (CD Pharmacy LLC)coreUtah-based pharmacy fulfillment partner for Hers prescriptions. Part of the pharmacy network that fills and ships medications.
- AnazaoHealth CorporationcorePharmacy fulfillment partner for Hers prescriptions. Part of the network handling prescription fulfillment and direct shipping to customers.
- Strive Specialties, Inc.corePharmacy fulfillment partner for Hers prescriptions and its affiliates. Part of the prescription fulfillment network.
- Medical Groups (You Health)coreMultiple medical groups including You Health of Alaska, California, Hawaii, Kansas, Nebraska, Nevada, New Jersey, and Texas P.C. These employ or contract with physicians and healthcare providers who offer clinical services through the Hers platform.
- Gifthealth, Inc.minorGifthealth provides access to manufacturer self-pay pharmacy solutions programs for certain weight loss prescriptions not available through Hers' primary pharmacy partners. Independent third-party pharmacy enabling broader medication access.
- HelloFresh, MyFitnessPal, LadderminorExclusive discount partners for Hers Weight Loss members. Provides lifestyle support through meal delivery, fitness tracking, and athletic wear discounts.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Hers competitors and assessment
Company assessmentDirect peers
- The Pill Club: The Pill Club is a telehealth birth control delivery service, directly competing with Hers' contraception offering through a similar online prescribing and pharmacy fulfillment model.
- Nurx: Nurx is a telehealth provider specializing in women's health, including birth control, STI testing, and herpes treatment — overlapping directly with Hers' birth control, mental health, and sexual wellness offerings.
- Found: Found is a telehealth weight-loss platform focused on GLP-1 prescriptions and metabolic care — a direct competitor to Hers' weight loss membership with similar cash-pay, GLP-1-centric positioning.
- Ro: Ro is a direct-to-consumer telehealth platform offering cash-pay virtual care across men's and women's health, including weight loss, sexual health, and hair loss — the closest comparable to Hers' cash-pay, DTC, multi-condition model.
- Tia: Tia is a women's healthcare provider combining virtual and in-person care across primary care, gynecology, and mental health — competing with Hers on the women's health platform category with a hybrid care delivery model.
- Maven Clinic: Maven Clinic is a virtual care platform focused on women's and family health covering fertility, pregnancy, postpartum, and menopause — a direct competitor in the women-focused telehealth category with strong employer and payer contracts.
- Hims: Hims is Hers' sister brand under Hims & Hers Health, offering the men's health equivalent of Hers' portfolio — identical business model, platform, pharmacy network, and membership mechanics, but targeted at men.
Broad incumbents
- Noom: Noom is a digital weight-loss platform combining behavior-change coaching with an increasingly prominent GLP-1 telehealth offering — a broader incumbent that overlaps with Hers' weight-loss category at a larger scale.
- Teladoc Health: Teladoc Health is a large public telehealth incumbent offering virtual care across many specialties including mental health, dermatology, and chronic care — a broad incumbent that competes with Hers in DTC virtual care, though with a B2B and payer-led model rather than cash-pay DTC.
- WW International (WeightWatchers): WW is the legacy weight-loss incumbent that has expanded into GLP-1 telehealth through its WeightWatchers Clinic offering — a broad incumbent now competing directly with Hers in cash-pay, GLP-1-supported weight management.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Hers social profiles
Digital presenceHers financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hers leadership team
Management profileNumber of profiles
Profiles5 records
Hers funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hers M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hers
What does Hers do?
Hers is a women-focused direct-to-consumer telehealth platform that connects patients with licensed healthcare providers via online questionnaires, asynchronous review, and 24/7 messaging. It dispenses FDA-approved prescription medications for weight loss (GLP-1s), hair loss, menopause hormone therapy, mental health, birth control, and sexual wellness, and offers subscription-based lab testing (Labs by Hers) processed through Quest Diagnostics. All services are cash-pay with no insurance required, and prescriptions are shipped in discreet packaging through partner pharmacies.
Is Hers a public or private company?
Hers is a public company. It is classified as public and is currently operating.
When was Hers founded?
Hers was founded in 2017. It employs 101 to 250 people.
Where is Hers based?
Hers is headquartered in San Francisco, United States, in the North America region.
How does Hers make money?
Six revenue lines are on record. Weight Loss Membership is the primary driver. The others are GLP-1 Medication Sales, lab Testing Subscriptions, hair Loss Treatment, menopause/Hormone Treatment and mental Health/Sexual Wellness.
Who are Hers's main competitors?
Direct peers on record are The Pill Club, Nurx, Found, Ro, Tia, Maven Clinic and Hims. Broad incumbents are Noom, Teladoc Health and WW International (WeightWatchers).
Does Hers have an API?
No public API is recorded for Hers.
What industry is Hers in?
Hers's product category is Women's Telehealth / Digital Health. Its primary akta.pro industry code is HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription), with a secondary code of HLALAAAD, Prescription-Based Digital Clinics (Condition-Specific Rx Programs). Its NAICS code is 6219 and its SIC code is 8000.